文献速递乳腺MR

集成深度学习模型对高危女性筛查乳腺MRI进行自动分诊

Automated Triage of Screening Breast MRI Examinations in High-Risk Women Using an Ensemble Deep Learning Model.
PubMed 文献 · Invest Radiol · 2023-04-11

本研究基于16,535例高危女性增强乳腺MRI,开发集成深度学习模型将最大强度投影图像分为「极低可疑」或「可能可疑」,外部验证中分诊11%筛查MRI为极低可疑且未漏诊任何癌症,敏感度100%、特异度11.5%,显示其可作为分诊工具减少阅片工作量。

要点

  • 模型将11%筛查MRI归为极低可疑,未漏诊癌症,敏感度100%。
  • 模型特异度仅11.5%,不宜独立诊断,应作为分诊工具。
  • 近期确诊乳腺癌患者MRI全部正确分诊为可能可疑。

核心结论

  • 集成深度学习模型可将部分筛查乳腺MRI分诊为极低可疑而不误分类任何癌症,有望减少阅片工作量。

研究设计与样本

  • 回顾性研究,收集2013年1月至2019年1月共16,535例高危女性增强乳腺MRI,来自纽约3个成像中心14,768例用于训练和验证,新泽西3个成像中心1,687例(含1,441例筛查MRI和246例近期确诊乳腺癌患者MRI)用于外部验证。
  • 模型基于最大强度投影图像训练分类为「极低可疑」或「可能可疑」,以组织病理学为参考标准评估工作量减少、敏感度和特异度,并开展读者研究比较模型与乳腺影像专科放射科医生表现。

诊断标准与关键数值

  • 外部验证集中,模型将159/1,441例筛查MRI分诊为极低可疑,未漏诊任何癌症,工作量减少11%,特异度11.5%,敏感度100%。
  • 模型将246/246例近期确诊乳腺癌患者MRI正确分诊为可能可疑,敏感度100%。
  • 读者研究中,2名放射科医生分类MRI的特异度分别为93.62%和91.49%,分别漏诊0例和1例癌症;深度学习模型特异度19.15%,漏诊0例癌症。

临床应用与阅片要点

  • 该模型可作为分诊工具,在独立模式下减少工作量,将低可疑病例分流给指定放射科医生或安排至工作日末尾处理,或作为其他下游AI工具的基础模型。
  • 模型特异度低,不应用于独立诊断,需结合放射科医生判读。

局限性

  • 回顾性研究设计。
  • 外部验证集样本量有限(1,687例MRI)。
  • 模型特异度较低(11.5%),可能增加假阳性分诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of the study is to develop and evaluate the performance of a deep learning (DL) model to triage breast magnetic resonance imaging (MRI) findings in high-risk patients without missing any cancers.

MATERIALS AND METHODS: In this retrospective study, 16,535 consecutive contrast-enhanced MRIs performed in 8354 women from January 2013 to January 2019 were collected. From 3 New York imaging sites, 14,768 MRIs were used for the training and validation data set, and 80 randomly selected MRIs were used for a reader study test data set. From 3 New Jersey imaging sites, 1687 MRIs (1441 screening MRIs and 246 MRIs performed in recently diagnosed breast cancer patients) were used for an external validation data set. The DL model was trained to classify maximum intensity projection images as "extremely low suspicion" or "possibly suspicious." Deep learning model evaluation (workload reduction, sensitivity, specificity) was performed on the external validation data set, using a histopathology reference standard. A reader study was performed to compare DL model performance to fellowship-trained breast imaging radiologists.

RESULTS: In the external validation data set, the DL model triaged 159/1441 of screening MRIs as "extremely low suspicion" without missing a single cancer, yielding a workload reduction of 11%, a specificity of 11.5%, and a sensitivity of 100%. The model correctly triaged 246/246 (100% sensitivity) of MRIs in recently diagnosed patients as "possibly suspicious." In the reader study, 2 readers classified MRIs with a specificity of 93.62% and 91.49%, respectively, and missed 0 and 1 cancer, respectively. On the other hand, the DL model classified MRIs with a specificity of 19.15% and missed 0 cancers, highlighting its potential use not as an independent reader but as a triage tool.

CONCLUSIONS: Our automated DL model triages a subset of screening breast MRIs as "extremely low suspicion" without misclassifying any cancer cases. This tool may be used to reduce workload in standalone mode, to shunt low suspicion cases to designated radiologists or to the end of the workday, or to serve as base model for other downstream AI tools.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Bhowmik, Monga, Belen, et al. Automated Triage of Screening Breast MRI Examinations in High-Risk Women Using an Ensemble Deep Learning Model. Invest Radiol. 2023. PMID: 37058323. doi:10.1097/RLI.0000000000000976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。